- Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia
Yasmin Abaza et al, 2020, American Journal of Hematology CrossRef - Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells
Ling Cheng et al, 2018, Cancer Biology & Therapy CrossRef - HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia
Menghan Liu et al, 2021, Frontiers in Oncology CrossRef - Decitabine Downregulates TIGAR to Induce Apoptosis and Autophagy in Myeloid Leukemia Cells
Lanzhu Li et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef - Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia
Mathilde Ruggiu et al, 2018, Leukemia & Lymphoma CrossRef